Further, in order to determine whether the expression of circulating miR-133a in CHD patients is superior to cTnI in the detection of the severity of coronary artery stenosis, 140 CHD patients were divided into 2 subgroups on the basis of cTnI levels (Figure 4A). The gene discussed is TNNI3; the disease is coronary artery disorder.